Sign in
4

Changes in Ownership

SAB Biotherapeutics, Inc. Filed Acc 0001493152-21-025510

Director bought 500 shares at $10.11 ($5,053)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Katz Ilan Director 2021-10-13 Purchase +500 $10.11 $5,053 1,500 D: show line 1 in the form
Open-market purchases · 500 sh · avg $10.11 · $5,053
Loading xslF345X03/ownership.xml…